Search Results

Ospemifene use in postmenopausal women

Authors: Gennari, Luigi; Merlotti, Daniela; Valleggi, Fabrizio; Nuti, Ranuccio

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 6, June 2009 , pp. 839-849(11)

Publisher: Informa Healthcare

Ospemifene shows promise for treating vaginal atrophy

Source: Inpharma, Volume 1, Number 1644, 2008-06-28 , pp. 9-9(1)

Publisher: Adis International

Pharmacologic Effects of Ospemifene in Rhesus Macaques: A Pilot Study

Authors: Wurz, Gregory T.; Hellmann-Blumberg, Utha; DeGregorio, Michael W.

Source: Basic & Clinical Pharmacology & Toxicology, Volume 102, Number 6, June 2008 , pp. 552-558(7)

Publisher: Blackwell Publishing

Ospemifene, a novel selective estrogen receptor modulator, appears to be beneficial for postmenopausal women with vaginal atrophy

Source: Inpharma, Volume 1, Number 1620, 2008-01-12 , pp. 19-19(1)

Publisher: Adis International

Selective Estrogen Receptor Modulators for Postmenopausal Osteoporosis: Current State of Development

Authors: Gennari, Luigi; Merlotti, Daniela; Valleggi, Fabrizio; Martini, Giuseppe; Nuti, Ranuccio

Source: Drugs & Aging, Volume 24, Number 5, 2007 , pp. 361-379(19)

Publisher: Adis International

Ineffectiveness of American Ginseng in the Prevention of Dimethylbenzanthracene-Induced Mammary Tumors in Mice

Authors: Wurz, Gregory T.; Marchisano-Karpman, Cristina; DeGregorio, Michael W.

Source: Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics, Volume 16, Number 6, 2006 , pp. 251-260(10)

Publisher: Cognizant Communication Corporation

Effects of ospemifene and raloxifene on biochemical markers of bone turnover in postmenopausal women

Authors: Komi, Janne; Lankinen, Kari S.; DeGregorio, Michael; Heikkinen, Jorma; Saarikoski, Seppo; Tuppurainen, Marjo; Halonen, Kaija; Lammintausta, Risto; Väänänen, Kalervo; Ylikorkala, Olavi; Erkkola, Risto

Source: Journal of Bone and Mineral Metabolism, Volume 24, Number 4, July 2006 , pp. 314-318(5)

Publisher: Springer

Emerging Selective Estrogen Receptor Modulators: Special Focus on Effects on Coronary Heart Disease in Postmenopausal Women

Authors: Vogelvang, Tatjana Elène; Marius Jan van der Mooren,; Mijatovic, Velja; Kenemans, Peter

Source: Drugs, Volume 66, Number 2, 2006 , pp. 191-221(31)

Publisher: Adis International

Effects of ospemifene, a novel SERM, on biochemical markers of bone turnover in healthy postmenopausal women

Authors: J. Komi; J. Heikkinen; M. Rutanen; K. Halonen; R. Lammintausta; O. Ylikorkala

Source: Gynecological Endocrinology, Volume 18, Number 3, March 2004 , pp. 152-158(7)

Publisher: Informa Healthcare

Novel therapies for osteoporosis

Author: Biskobing D.M.

Source: Expert Opinion on Investigational Drugs, Volume 12, Number 4, 1 April 2003 , pp. 611-621(11)

Publisher: Informa Healthcare

Pharmacokinetics of Selective Estrogen Receptor Modulators

Authors: Morello K.C.; Wurz G.T.; DeGregorio M.W.

Source: Clinical Pharmacokinetics, Volume 42, Number 4, 2003 , pp. 361-372(12)

Publisher: Adis International

Effects of ospemifene (FC-1271a) on uterine endometrium, vaginal maturation index, and hormonal status in healthy postmenopausal women

Authors: Voipio S.K.; Komi J.; Kangas L.; Halonen K.; DeGregorio M.W.; Erkkola R.U.

Source: Maturitas, Volume 43, Number 3, 20 November 2002 , pp. 207-214(8)

Publisher: Elsevier

In vitro and in vivo biologic effects of Ospemifene (FC-1271a) in breast cancer

Authors: Taras T.L.; Wurz G.T.; DeGregorio M.W.

Source: The Journal of Steroid Biochemistry and Molecular Biology, Volume 77, Number 4, June 2001 , pp. 271-279(9)

Publisher: Elsevier